ruboxistaurin has been researched along with Neovascularization, Optic Disc in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chikaraishi, Y; Hara, H; Nakamura, S; Shimazawa, M; Tsuruma, K | 1 |
Bingaman, DP; Danis, RP; Jirousek, M; Yang, Y | 1 |
2 other study(ies) available for ruboxistaurin and Neovascularization, Optic Disc
Article | Year |
---|---|
Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Indoles; Maleimides; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Protein Kinase C; Protein Kinase C beta; Proto-Oncogene Proteins c-akt; Retinal Neovascularization; Umbilical Veins; Vascular Endothelial Growth Factor A | 2010 |
Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKCbeta inhibition with LY333531.
Topics: Administration, Oral; Animals; Enzyme Inhibitors; Fluorescein Angiography; Fundus Oculi; Indoles; Ischemia; Male; Maleimides; Photography; Protein Kinase C; Retinal Neovascularization; Retinal Vein Occlusion; Swine | 1998 |